/MYO
MYO Stock - Myomo, Inc.
Healthcare|Medical - DevicesNYSE
$0.93+3.50%
+$0.03 (+3.50%) • Dec 19
65
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.16
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.79
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+918.8%upside
Target: $9.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MYO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.92 – $0.94
TARGET (TP)$9.50
STOP LOSS$0.86
RISK/REWARD1:118.2
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.02
52W High$7.17
52W Low$0.71
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $32.55M | $19.24M | $15.56M | $13.86M | $7.58M |
| Gross Profit | $23.19M | $13.18M | $10.25M | $10.31M | $4.98M |
| Gross Margin | 71.2% | 68.5% | 65.9% | 74.4% | 65.7% |
| Operating Income | $-6,206,698 | $-8,231,549 | $-10,672,204 | $-10,268,065 | $-10,502,686 |
| Net Income | $-6,183,729 | $-8,147,565 | $-10,721,022 | $-10,372,329 | $-11,563,911 |
| Net Margin | -19.0% | -42.3% | -68.9% | -74.9% | -152.5% |
| EPS | $-0.16 | $-0.28 | $-1.52 | $-1.78 | $-3.62 |
Company Overview
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
3 Bullish0 Neutral/Bearish
Price Targets
$7
Average Target
↑ 632.8% Upside
Now
$7
Low
$7
Average
$7
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| July 31st 2024 | Craig Hallum | Initiation | Buy | $7 |
| May 20th 2024 | Lake Street | Initiation | Buy | $7 |
| December 15th 2023 | H.C. Wainwright | Initiation | Buy | $6.5 |
Earnings History & Surprises
MYOBeat Rate
61%
Last 18 quarters
Avg Surprise
+10.9%
EPS vs Estimate
Beats / Misses
11/5
2 met exactly
Latest EPS
$-0.09
Q4 2025
EPS Surprise History
Q1 24
-40.0%
$-0.07vs$-0.05
Q2 24
-11.1%
$-0.10vs$-0.09
Q3 24
+57.1%
$-0.03vs$-0.07
Q4 24
-28.6%
$-0.03vs$-0.02
Q1 25
+50.0%
$-0.01vs$-0.02
Q2 25
0.0%
$-0.08vs$-0.08
Q3 25
0.0%
$-0.11vs$-0.11
Q4 25
+18.2%
$-0.09vs$-0.11
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 5, 2026 | — | — | — | — |
Q1 2026 | Mar 9, 2026 | $-0.09 | — | — | — |
Q4 2025 | Nov 10, 2025 | $-0.11 | $-0.09 | +18.2% | ✓ BEAT |
Q3 2025 | Aug 11, 2025 | $-0.11 | $-0.11 | 0.0% | = MET |
Q2 2025 | May 7, 2025 | $-0.08 | $-0.08 | 0.0% | = MET |
Q1 2025 | Mar 10, 2025 | $-0.02 | $-0.01 | +50.0% | ✓ BEAT |
Q4 2024 | Nov 6, 2024 | $-0.02 | $-0.03 | -28.6% | ✗ MISS |
Q3 2024 | Aug 6, 2024 | $-0.07 | $-0.03 | +57.1% | ✓ BEAT |
Q2 2024 | May 8, 2024 | $-0.09 | $-0.10 | -11.1% | ✗ MISS |
Q1 2024 | Mar 7, 2024 | $-0.05 | $-0.07 | -40.0% | ✗ MISS |
Q4 2023 | Nov 7, 2023 | $-0.08 | $-0.06 | +25.0% | ✓ BEAT |
Q3 2023 | Aug 9, 2023 | $-0.03 | $-0.04 | -23.1% | ✗ MISS |
Q2 2023 | May 10, 2023 | $-0.15 | $-0.11 | +26.7% | ✓ BEAT |
Q1 2023 | Mar 13, 2023 | $-0.44 | $-0.29 | +34.1% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $-0.47 | $-0.40 | +14.9% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $-0.45 | $-0.42 | +6.7% | ✓ BEAT |
Q2 2022 | May 11, 2022 | $-0.54 | $-0.41 | +24.1% | ✓ BEAT |
Q1 2022 | Mar 9, 2022 | $-0.49 | $-0.52 | -6.1% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-0.47 | $-0.36 | +23.4% | ✓ BEAT |
Q3 2021 | Aug 9, 2021 | $-0.62 | $-0.46 | +25.8% | ✓ BEAT |
Latest News
Myomo Affirms FY2025 Sales Guidance of $40.000M-$42.000M vs $40.188M Est
📈 PositiveBenzinga•Nov 10, 2025, 09:08 PM
Myomo Q3 EPS $(0.09), Inline, Sales $10.091M Beat $9.438M Estimate
📈 PositiveBenzinga•Nov 10, 2025, 09:08 PM
Ascendiant Capital Maintains Buy on Myomo, Lowers Price Target to $10.5
📈 PositiveBenzinga•Sep 22, 2025, 09:57 AM
Frequently Asked Questions about MYO
What is MYO's current stock price?
Myomo, Inc. (MYO) is currently trading at $0.93 per share. The stock has moved +3.50% today.
What is the analyst price target for MYO?
The average analyst price target for MYO is $9.50, based on 1 analyst.
What sector is Myomo, Inc. in?
Myomo, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NYSE exchange.
What is MYO's market cap?
Myomo, Inc. has a market capitalization of $0.04 billion, making it a small-cap company.
Does MYO pay dividends?
No, Myomo, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorECOR
electroCore, Inc.
$4.60
Mkt Cap: $0.0B
HYPD
Hyperion DeFi, Inc.
$3.67
Mkt Cap: $0.0B
IGC
IGC Pharma, Inc.
$0.30
Mkt Cap: $0.0B
MIRA
MIRA Pharmaceuticals, Inc.
$1.63
Mkt Cap: $0.1B
MLSS
Milestone Scientific Inc.
$0.32
Mkt Cap: $0.0B
MODD
Modular Medical, Inc.
$0.34
Mkt Cap: $0.0B
NMTC
NeuroOne Medical Technologies Corporation
$0.73
Mkt Cap: $0.0B
NXL
Nexalin Technology, Inc.
$0.83
Mkt Cap: $0.0B
POCI
Precision Optics Corporation, Inc.
$4.08
Mkt Cap: $0.0B
RBOT
Vicarious Surgical Inc.
$2.17
Mkt Cap: $0.0B
Explore stocks similar to MYO for comparison